Pembrolizumab plus pemetrexed‐platinum for metastatic nonsquamous non–small‐cell lung cancer: KEYNOTE‐189 Japan Study

Advanced non-small cell lung cancer – Treatment with Pembrolizumab

(2020) Antonio Silvinato et al.   Revista da Associacao Medica Brasileira

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer

(2020) Shirish Gadgeel et al.   JOURNAL OF CLINICAL ONCOLOGY

How to Make the Best Use of Immunotherapy as First-Line Treatment for Advanced/Metastatic Non–Small-Cell Lung Cancer

(2019) Solange Peters et al.   ANNALS OF ONCOLOGY

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

(2019) Hiroaki Akamatsu et al.   International Journal of Clinical Oncology

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

(2019) et al.   JAMA Oncology

MO3-9-3Primary results from Japanese phase I study of pembrolizumab plus chemotherapy as front-line therapy for advanced NSCLC

(2019) Takayasu Kurata et al.   ANNALS OF ONCOLOGY

Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer

(2018) Martin Reck   Immunotherapy

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

(2018) Leena Gandhi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunotherapy in the Asiatic population: any differences from Caucasian population?

(2018) Lunxi Peng et al.   Journal of Thoracic Disease

New windows open for immunotherapy in lung cancer

(2018) Lizza Hendriks et al.   NATURE

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

(2018) Luis Paz-Ares et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small cell lung cancer; a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS

(2018) Y -L Wu et al.   ANNALS OF ONCOLOGY

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

(2016) S. Novello et al.   ANNALS OF ONCOLOGY

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study

(2016) Corey J Langer et al.   LANCET ONCOLOGY

Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy

(2012) Ross A Soo et al.   Future Oncology

Ethnic Differences in Survival Outcome in Patients with Advanced Stage Non-small Cell Lung Cancer: Results of a Meta-Analysis of Randomized Controlled Trials

(2011) Ross A. Soo et al.   Journal of Thoracic Oncology